Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham ...

About Merck At Merck, known as MSD outside of the ... statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2024 and the company’s other filings ...

India], March 7: Merck Foundation, the philanthropic arm of Merck KGaA Germany together with First Ladies of Africa who are ...

February 19, 2025, the company was named an Advanced Partner under the X Ads Agency Certification Program by X Corp. Japan K.K. Among all certified advertising agencies, X Corp. Japan K.K. recognizes ...

Explore why Recursion Pharmaceuticals' AI-driven drug discovery faces challenges in revenue growth, governance, and investor ...

How A Fragmented Digital Landscape Is Failing K-12 Education, sheds light on the growing complexities of digital integration in education. With a universe of educational applications available, the ...

Q4 2024 Earnings Call Transcript March 11, 2025 Voyager Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

Vaccinex intends to file a Form 25 with the Securities and Exchange Commission on or about March 17, 2025 to remove its Common Stock from listing on Nasdaq.

Pete Stavropoulos; Analyst; Cantor Fitzgerald & Co. Good afternoon and welcome to Voyager Therapeutics fourth-quarter and year-end 2024 financial results conference call. (Operator Instructions) ...

Stelios Papadopolous, Ph.D., a pioneering leader in biotech, appointed to Board of Directors; two industry veterans joined management team as ...